Jeremie Calais

Identifiants chercheurs

IdHAL :

jeremie-calais

ORCID :

0000-0002-8839-4379

IdRef :

181743043

ResearcherID :

AAG-7119-2020

Publications

Article dans une revue (10)

Funding Reductions Threaten the Future of Medical Innovation Johannes Czernin,Carolyn J Anderson,Ramsey Derek Badawi,Henryk Barthel,Frank M Bengelet al. Journal of Nuclear Medicine, 2025 Article dans une revue hal-05405462v1
Future directions in the evaluation and management of newly diagnosed metastatic cancer Eric J Lehrer,Chachrit Khunsriraksakul,Sara Garrett,Daniel M Trifiletti,Jason P Sheehanet al. Critical Reviews in Oncology/Hematology, 2025, 208, pp.104631. ⟨10.1016/j.critrevonc.2025.104631⟩ Article dans une revue hal-05405407v1
SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors Thomas Hope,Martin Allen-Auerbach,Lisa Bodei,Jeremie Calais,Magnus Dahlbomet al. Journal of Nuclear Medicine, 2023, 64 (2), pp.204-210. ⟨10.2967/jnumed.122.264860⟩ Article dans une revue hal-04122566v1
Correlation Between FDG Hotspots on Pre-radiotherapy PET/CT and Areas of HNSCC Local Relapse : Impact of Treatment Position and Images Registration Method Blandine Truffault,David Bourhis,Anne Chaput,Jérémie Calais,Philippe Robinet al. Frontiers in Medicine, 2020, 7, pp.218. ⟨10.3389/fmed.2020.00218⟩ Article dans une revue hal-02922556v1
Non-Invasive Imaging Techniques to Assess Myocardial Perfusion Olivier Villemain,Jerome Baranger,Zakaria Jalal,Christopher Lam,Jérémie Calaiset al. Expert Review of Medical Devices, 2020, 17 (11), pp.1133--1144. ⟨10.1080/17434440.2020.1834844⟩ Article dans une revue hal-04072558v1
Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma Anne Chaput,Jérémie Calais,Philippe Robin,Sébastien Thureau,David Bourhiset al. Archives of Otorhinolaryngology - Head & Neck Surgery, 2017, 39 (6), pp.1155 - 1165. ⟨10.1002/hed.24738⟩ Article dans une revue hal-01643973v1
High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for locally advanced oesophageal cancer. Jérémie Calais,Bernard Dubray,Lamyaa Nkhali,Sebastien Thureau,Charles Lemarignieret al. European Journal of Nuclear Medicine and Molecular Imaging, 2015, European Journal of Nuclear Medicine and Molecumar Imaging, 42 (6), pp.858-67 Article dans une revue hal-01117229v1
Areas of High 18F-FDG Uptake on Preradiotherapy PET/CT Identify Preferential Sites of Local Relapse After Chemoradiotherapy for Non-Small Cell Lung Cancer. Jérémie Calais,Sébastien Thureau,Bernard Dubray,Romain Modzelewski,Luc Thibervilleet al. Journal of Nuclear Medicine, 2015, 56 (2), pp.196-203 Article dans une revue hal-01117241v1
Tc-99m-HMPAO-Labeled Leukocyte SPECT/CT in Pediatrics: Detecting Candida albicans Tricuspid Endocarditis Jérémie Calais,Agathe Edet-Sanson,Stephane Gaucher,Pierre Vera,Joseph Le Cloirec The quarterly journal of nuclear medicine and molecular imaging, 2015, pp.1-8. ⟨10.1007/s13139-015-0333-5⟩ Article dans une revue hal-01145000v1
Hodgkin's Disease Staging by FDG PET/CT in a Pregnant Woman. Jérémie Calais,Sébastien Hapdey,Hervé Tilly,Pierre Vera,Mathieu Chastan European Journal of Nuclear Medicine and Molecular Imaging, 2014, 48 (3), pp.244-6 Article dans une revue hal-01141157v1

HDR (1)

Clinical and Translational Research in Radiotheranostics Jeremie Calais Nuclear medicine. University Paris-Saclay, 2024 HDR tel-04784294v1

Thèse (1)

Théranostique ciblant le PSMA : de la recherche clinique a la norme de soins standards Jérémie Calais Physique Médicale [physics.med-ph]. Université Paris-Saclay, 2023. Français. ⟨NNT : 2023UPAST192⟩ Thèse tel-04403563v1

Communication dans un congrès (3)

High FDG uptake areas on pre-radiotherapy PET/CT identify preferential sites of local relapse after chemo-radiotherapy for locally advanced oesophageal cancer Jérémie Calais,Bernard Dubray,Lamyaa Nkhali,Sébastien Thureau,Charles Lemarignieret al. Axe 3 du Cancéropôle Nord-Ouest, 2015, Lille, France Communication dans un congrès hal-01153177v1
Prospective comparison of FDG PET/CT and diffusion-weighted MRI for para-aortic metastases detection in cancer of the uterine cervix. Mathieu Chastan,Agathe Edet-Sanson,Marc Baron,Françoise Callonnec,Stéphanie Beckeret al. SNM 60th Annual Meeting, 2013, Vancouver, Canada. pp.54 Communication dans un congrès hal-00944982v1
High FDG uptake areas on pre-radiotherapy PET/CT identifies preferential sites of locl recurrence in non small cell lung cancer (NSCLC) patients. Jérémie Calais,Sébastien Thureau,Bernard Dubray,Romain Modzelewski,Isabelle Gardinet al. Annual Congress of the European Association of Nuclear Medicine., Oct 2013, Lyon, France. pp.S224 Communication dans un congrès hal-00945957v1

Poster de conférence (1)

The 70% of SUVmax threshold on pre radiotherapy PET/CT identifies the site of local recurrence in lung cancer Jérémie Calais,Bernard Dubray,Lamyaa Nkhali,Sébastien Thureau,Charles Lemarignieret al. Annual meeting of the European Society for Radiotherapy and Oncology, 2014, Vienne, Austria Poster de conférence hal-01153475v1

Mémoire d'étudiant (1)

Les sous-volumes intra-tumoraux les plus hypermétaboliques en TEP au FDG sont à haut risque de récidive locale après radiochimiothérapie dans le cancer broncho-pulmonaire et le cancer de l'œsophage Jérémie Calais Médecine humaine et pathologie. 2014 Mémoire d'étudiant dumas-01083363v1